Miniatura

Fitxers

568771.pdf (187.12 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2003

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/22446

Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1136/ard.62.5.431

Resum

Background: Anti-chromatin antibodies have recently been described in patients with systemic lupus erythematosus (SLE) and it has been suggested that their presence is associated with lupus nephritis. Objective: To assess the prevalence and clinical associations of these antibodies in SLE. Methods: The presence of anti-chromatin antibodies in 100 patients with SLE was investigated by an enzyme linked immunosorbent assay (ELISA). To determine the specificity of these antibodies, 100 patients with primary Sjögren’s syndrome, 30 with primary antiphospholipid syndrome (APS), 10 with systemic sclerosis, and 100 normal controls were also tested. Results: Positive levels were detected in 69/100 (69%) patients with SLE. In contrast, they were found in only 8/100 (8%) of those with primary Sjögren’s syndrome, in 1/10 (10%) with systemic sclerosis, in 2/30 (7%) with primary APS, and in none of the 100 healthy controls. Patients with anti-chromatin antibodies had a twofold higher prevalence of lupus nephropathy than those without these antibodies (58% v 29%, p<0.01). A significant correlation was found between the levels of anti-chromatin antibodies and disease activity score as measured by the European Consensus Lupus Activity Measurement (ECLAM; p=0.011). Conclusions: The measurement of anti-chromatin antibodies appears to be a useful addition to the laboratory tests that can help in the diagnosis and treatment of SLE. These antibodies are both sensitive and specific for SLE, and are a useful marker for an increased risk of lupus nephritis.

Matèries

Lupus eritematós, Malalties del ronyó, Immunoglobulines

Matèries (anglès)

Lupus erythematosus, Kidney diseases, Immunoglobulins

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

CERVERA I SEGURA, Ricard, VIÑAS I FOLCH, Octavi, RAMOS CASALS, Manuel, FONT FRANCO, Josep, GARCÍA CARRASCO, Mario, SISÓ ALMIRALL, Antoni, RAMÍREZ, F., MACHUCA, Y., VIVES I CORRONS, Joan lluís, INGELMO MORÍN, Miguel, BURLINGAME, R. w.. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.. _Annals of the Rheumatic Diseases_. 2003. Vol. 62, núm. 5, pàgs. 431-434. [consulta: 21 de gener de 2026]. ISSN: 0003-4967. [Disponible a: https://hdl.handle.net/2445/22446]

Exportar metadades

JSON - METS

Compartir registre